Capstone Therapeutics Corp. (OTCPK:CAPS) announced a private placement of 2,496,667 common shares at a price of $0.60 per share for gross proceeds of $1,498,000 on April 6, 2021. The transaction included participation among five accredited investors, including four private equity funds. The securities issued have a hold period.